Spiro tetracyclic compound

C - Chemistry – Metallurgy – 07 – D

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C07D 471/22 (2006.01) A61K 31/499 (2006.01) A61P 7/02 (2006.01) A61P 9/10 (2006.01) A61P 43/00 (2006.01)

Patent

CA 2651420

Disclosed is an anti-coagulant which has extremely excellent inhibitory effect on FXa and an extremely poor inhibitory effect on hERG channel, and can be administered through the oral route. Specifically, disclosed is a compound represented by the formula (I) or a pharmaceutically acceptable salt thereof.

L'invention concerne un anticoagulant ayant un effet inhibiteur de FXa particulièrement excellent et un effet inhibiteur du canal hERG particulièrement faible, ledit anticoagulant pouvant être administré par voie orale. L'invention concerne plus spécifiquement un composé répondant à la formule (I) ou l'un de ses sels acceptable sur le plan pharmaceutique.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Spiro tetracyclic compound does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Spiro tetracyclic compound, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Spiro tetracyclic compound will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1714110

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.